134 related articles for article (PubMed ID: 32759183)
1. Management of low-grade serous ovarian neoplasm in the setting of fertility preservation.
Marchocki Z; Rouzbahman M; Chawla T; May T
Int J Gynecol Cancer; 2020 Nov; 30(11):1834-1839. PubMed ID: 32759183
[No Abstract] [Full Text] [Related]
2. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography.
Rohsbach D; Trillsch F; Regier M; Choschzick M; Kommoss F; Hermsteiner M; Töllner T; Mattner UM; Jaenicke F; Mahner S
J Clin Oncol; 2011 Oct; 29(30):e763-5. PubMed ID: 21931030
[No Abstract] [Full Text] [Related]
4. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
Jones BP; Saso S; Farren J; El-Bahrawy M; Ghaem-Maghami S; Smith JR; Yazbek J
Int J Gynecol Cancer; 2017 Nov; 27(9):1813-1818. PubMed ID: 28763365
[TBL] [Abstract][Full Text] [Related]
5. A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Müllerian tumor).
Song MJ; Lee CW; Seo KJ; Kim JA; Park JS; Hur SY
Eur J Gynaecol Oncol; 2011; 32(2):234-6. PubMed ID: 21614928
[TBL] [Abstract][Full Text] [Related]
6. [External multicentric validation of two scores predicting the risk of relapse in patients with borderline ovarian tumors: The nomogram of Bendifallah and the score of Ouldamer].
Pais P; Huchon C; Chevrot A; Cohen J; Fauconnier A; Rouzier R; Mimouni M
Bull Cancer; 2017 Sep; 104(9):721-726. PubMed ID: 28778341
[TBL] [Abstract][Full Text] [Related]
7. The limits of aggressive surgical cytoreduction.
Levine DA
Gynecol Oncol; 2018 Aug; 150(2):205-206. PubMed ID: 30025830
[No Abstract] [Full Text] [Related]
8. Application of real-time ultrasound elastography for discrimination of low- and high-grade serous ovarian carcinoma.
Xie M; Zhang X; Zhan J; Hua K
J Ultrasound Med; 2013 Feb; 32(2):257-62. PubMed ID: 23341381
[TBL] [Abstract][Full Text] [Related]
9. Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation.
Hachem HE; Poulain M; Höher M; Fanchin R; Frydman R; Grynberg M
Future Oncol; 2014 Oct; 10(12):1907-12. PubMed ID: 25386809
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
[TBL] [Abstract][Full Text] [Related]
11. Ex-vivo oocyte retrieval for fertility preservation.
Fatemi HM; Kyrou D; Al-Azemi M; Stoop D; De Sutter P; Bourgain C; Devroey P
Fertil Steril; 2011 Apr; 95(5):1787.e15-7. PubMed ID: 21130426
[TBL] [Abstract][Full Text] [Related]
12. Serous papillary cystadenocarcinoma in supernumerary ovary.
Nomelini RS; Oliveira LJ; Jammal MP; Adad SJ; Murta EF
J Obstet Gynaecol; 2013 Apr; 33(3):324. PubMed ID: 23550880
[No Abstract] [Full Text] [Related]
13. The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
Katsakhyan L; Baraban EG; Dumoff KL; Burger RA; Parikh R; Cooper K
Int J Gynecol Pathol; 2021 Mar; 40(2):175-179. PubMed ID: 32168063
[TBL] [Abstract][Full Text] [Related]
14. Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report.
Catteau X; Preat F; D'haene N; Noël JC
Int J Gynecol Pathol; 2021 Sep; 40(5):448-451. PubMed ID: 33252399
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in studies of ovarian serous and mucinous borderline ovarien tumors].
Shao HL; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):173-5. PubMed ID: 16630508
[No Abstract] [Full Text] [Related]
16. Low grade serous ovarian carcinoma: identifying variations in practice patterns.
Siemon J; Gershenson DM; Slomovitz B; Schlumbrecht M
Int J Gynecol Cancer; 2019 Jan; 29(1):174-180. PubMed ID: 30640701
[TBL] [Abstract][Full Text] [Related]
17. Primary retroperitoneal serous cystadenocarcinoma of 'ovarian-type': US and CT findings.
Caruncho M; Pombo F; Arnal-Monreal F
Eur J Radiol; 1993 Sep; 17(2):115-6. PubMed ID: 8223678
[No Abstract] [Full Text] [Related]
18. High-Grade Serous Ovarian Cancer: Use of Machine Learning to Predict Abdominopelvic Recurrence on CT on the Basis of Serial Cancer Antigen 125 Levels.
Shinagare AB; Balthazar P; Ip IK; Lacson R; Liu J; Ramaiya N; Khorasani R
J Am Coll Radiol; 2018 Aug; 15(8):1133-1138. PubMed ID: 29789232
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244
[TBL] [Abstract][Full Text] [Related]
20. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
